Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution

Ana Paula Moreira1, Cory M Hogaboam

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-2200, USA.

Insights

In asthma, lung macrophages become improperly activated. Restoring balance between M1, M2, and regulatory macrophages may effectively treat asthma.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • Macrophages are crucial for respiratory tract defense against pathogens.
  • These immune cells recognize, engulf, and eliminate infectious agents, aiding tissue repair.
  • In asthma, macrophages exhibit inappropriate activation in the lung's alveolar spaces.

Purpose of the Study:

  • To investigate the role and activation states of macrophages in asthma.
  • To understand the distinct phenotypes of macrophages in asthmatic lungs.
  • To explore potential therapeutic strategies targeting macrophage balance in asthma.

Main Methods:

  • Analysis of macrophage populations (M1, M2, and immunoregulatory) in the lungs of asthma patients.
  • Assessment of macrophage polarization in alveolar versus interstitial lung compartments.
  • Evaluation of interleukin-10 expression in interstitial macrophages.

Main Results:

  • Both classically activated (M1) and alternatively activated (M2) macrophages are present in the alveolar compartment of asthmatic lungs.
  • Interstitial macrophages show less M1/M2 polarization and express interleukin-10, indicating immunoregulatory functions.
  • An imbalance in macrophage phenotypes is observed in asthmatic lungs.

Conclusions:

  • Macrophage dysregulation contributes to asthma pathogenesis.
  • Restoring a balanced milieu of M1, M2, and immunoregulatory macrophages is a potential therapeutic goal for asthma.
  • Targeting macrophage polarization may offer effective asthma treatment strategies.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...